Like other vaccines available in the U.S., Pfizer-BioNTech have been providing their vaccine under an emergency use authorization.
Author: Karen Weintraub, USA TODAY
‘Like somebody gave me a happy pill:’ Monoclonal antibodies are helping the Americans most at risk for COVID-19
The therapy can be life-saving, especially in the early stages of an infection, and it’s becoming easier to access across the US.
Should US share its COVID-19 vaccine supply with the world? The White House says it will – but not yet.
International community members say the U.S. and other richer nations should be sharing more its COVID-19 vaccine supply with the rest of the world.
COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows
More recent clinical trial results show AstraZeneca’s COVID-19 vaccine is slightly less effective in stopping disease than the company first reported.
Moncef Slaoui, former Operation Warp Speed science chief, fired by drugmaker GSK for sexual harassment
Moncef Slaoui, a former head of Operation Warp Speed, who spearheaded COVID-19 vaccine development in the USA, was fired by GSK for harassing an employee.
‘It’s easy to scare people’: Europe’s decision to pull AstraZeneca-Oxford vaccine threatens global COVID-19 recovery efforts, US experts say
As AstraZeneca defends its COVID-19 vaccine following a European pause, the World Health Organization says there is no reason to stop using it.
People with immune issues – at ‘high risk’ for COVID-19 – remain hesitant about vaccination. Here’s what experts say
Organizations representing experts in cancer, organ transplantation and autoimmune diseases support COVID-19 vaccination for their patients.
What science has learned works and what doesn’t in COVID treatments
A year into treating those with COVID-19, research is revealing medical interventions, such as remdesivir, that help patients, and some that don’t.
Johnson & Johnson COVID-19 vaccine, which requires just one shot, is on track to become third allowed for use in US
The Food and Drug Administration is expected to act quickly to authorize J&J’s one-dose COVID-19 vaccine after an advisory panel meets Friday.
Moderna to begin trial of new COVID vaccine to address virus variant first found in South Africa
Moderna’s trial of a new COVID-19 vaccine will target the virus variant that first emerged in South Africa. Other vaccine makers plan similar studies.